ArticleOncotarget2017

Anthropometric, clinical and molecular determinants of treatment outcomes in postmenopausal, hormone receptor positive metastatic breast cancer patients treated with fulvestrant: Results from a real word setting.

Laura Pizzuti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.